![]() Cagrilintide structure
|
Common Name | Cagrilintide | ||
---|---|---|---|---|
CAS Number | 1415456-99-3 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CagrilintideCagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity[1][2][3]. |
Name | Cagrilintide |
---|
Description | Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity[1][2][3]. |
---|---|
Related Catalog | |
In Vivo | Cagrilintide (compound 23) (0.1, 1, 3, 10, 30 nmol/kg; s.c.) reduces food intake in the rat[2]. Cagrilintide (10 nmol/kg; i.v. or s.c.) shows good pharmacokinetic parameters[2]. Animal Model: 12 weeks, 400 g Sprague Dawley male rats[2] Dosage: 0.1, 1, 3, 10, 30 nmol/kg Administration: S.c.; once for 80 h Result: Reduced food intake in the rat for several days at doses in the range of 1-10 nmol/kg. Animal Model: 12 weeks, 400 g Sprague Dawley male rats[2] Dosage: 10 nmol/kg Administration: I.v.; s.c. Result: Showed good pharmacokinetic parameters with T1/2 of 20±2, 27±3 h for i.v. and s.c., respectively. |
References |
No Any Chemical & Physical Properties |